Inactive Instrument

Insiders Sanofi Euronext Paris

Stocks

SANNV

FR001400UEY9

Pharmaceuticals

Insiders

04-29	Sanofi Announces Board and Committee Changes	CI
04-07	Sanofi: Treatment for re-rating isn’t easy
03-05	Sanofi Announces Resignation of Patrick Kron as Independent Director and Chairman of the Nomination, Governance and Csr Committee	CI
02-24	Alveus Therapeutics, Inc. announced that it has received $197 million in funding from a group of investors	CI
02-17	Sanofi Announces Executive Changes	CI
02-17	Sanofi appoints Manuela Buxo as head of specialty care	RE
02-13	PRESS DIGEST-Financial Times - February 13	RE
02-12	Jefferies Identifies the Key Challenge for Sanofi's New CEO
02-12	Sanofi Shares Fall After CEO Change	DJ
02-12	Sanofi Announces Chief Executive Officer Changes	CI
02-12	The Pill Is Hard to Swallow for Investors
02-12	Sanofi Names Belen Garijo as Chief Executive	MT
02-12	Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant	RE
02-12	Belén Garijo to become chief executive officer of Sanofi	RE
02-12	Sanofi appoints Belén Garijo as new CEO after deciding not to renew current CEO Hudson's mandate	RE
02-12	Sanofi Names Merck KGaA's Belen Garijo to Replace Paul Hudson as CEO -- Update	DJ
02-12	Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant	RE
02-12	Sanofi Names Belen Garijo to Replace Paul Hudson as CEO	DJ
02-12	Sanofi Appoints Former Merck KGaA Executive as New CEO	MT
02-12	Belén Garijo to Replace Paul Hudson as Head of Sanofi
01-08	Alveus Therapeutics ApS announced that it has received $159.8 million in funding from New Rhein Healthcare Investors, LLC, Andera Partners, Omega Fund Management, LLC, Kurma Partners SA, Avego BioScience Capital, Sanofi and other investors	CI
01-07	Alveus Therapeutics, Inc. amended terms of the transaction	CI
08/10/25	Biovaxys appoints former Sanofi Vaccines executive to board of directors	RE
01/07/25	Sanofi: Pipeline disappointments may push out the CEO
30/04/25	Sanofi Appoints Clotilde Delbos as Chairwoman of the Compensation Committee	CI